Revelation Biosciences, Inc. to Present at the 2023 ROTH Healthcare Opportunities Conference
04 Ottobre 2023 - 3:00PM
Business Wire
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or
“Revelation”), a life sciences company that is focused on
harnessing the power of trained immunity for the prevention and
treatment of disease, today announced that its Chief Executive
Officer James Rolke will be presenting at the upcoming 2023 ROTH
Healthcare Opportunities Conference being held in New York, NY
on October 12, 2023. Mr. Rolke will also be participating in
one-on-one investor meetings at the conference.
Roth 2023 Healthcare Opportunities Conference
Date:
Thursday, October 12, 2023
Time:
8:45 a.m. Eastern Time
Location:
Tap Room - 3rd Floor @ The Yale Club, New
York, NY
Register:
https://www.meetmax.com/sched/event_95633/conference_register.html
Please contact your ROTH representative to schedule one-on-one
meetings with the management team during the conference.
About Revelation Biosciences, Inc.
Revelation Biosciences, Inc. is a life sciences company focused
on the development of therapies for the prevention and treatment of
disease using trained immunity. Revelation’s product candidates are
based on the Gemini formulation of phosphorylated hexaacyl
disaccharide (PHAD) and its well-established effect on the innate
immune system. Our two lead programs include evaluating Gemini as a
potential therapy for the treatment of acute and chronic organ
disease including acute kidney injury (AKI), chronic kidney disease
(CKD) and myocarditis (REVTx-300) and as a potential prevention and
treatment of hospital acquired infection (REVTx‑100).
For more information on Revelation, please visit
www.RevBiosciences.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231004390260/en/
Sandra Vedrick Vice President, Investor Relations & Human
Resources Revelation Biosciences, Inc. Email:
svedrick@revbiosciences.com
and
Chester Zygmont, III Chief Financial Officer Revelation
Biosciences, Inc. Email: czygmont@revbiosciences.com
Grafico Azioni Revelation Biosciences (NASDAQ:REVB)
Storico
Da Apr 2024 a Mag 2024
Grafico Azioni Revelation Biosciences (NASDAQ:REVB)
Storico
Da Mag 2023 a Mag 2024
